Anfield Capital Management, LLC Viatris Inc Transaction History
Anfield Capital Management, LLC
- $258 Million
- Q1 2025
A detailed history of Anfield Capital Management, LLC transactions in Viatris Inc stock. As of the latest transaction made, Anfield Capital Management, LLC holds 507 shares of VTRS stock, worth $4,633. This represents 0.0% of its overall portfolio holdings.
Number of Shares
507
Previous 507
-0.0%
Holding current value
$4,633
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VTRS
# of Institutions
1,128Shares Held
959MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.32 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$847 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$681 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$594 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$562 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11.1B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...